A genome-wide association study combining pathway analysis for typical sporadic amyotrophic lateral sclerosis in Chinese Han populations

Neurobiology of Aging

Volumn 35, Issue 7, 2014, Pages 1778.e9-1778.e23

  Xie, Tong ^a   Deng, Libin ^a   Mei, Puming ^a   Zhou, Yiyi ^a   Wang, Bo ^a   Zhang, Jie ^a   Lin, Jiari ^a   Wei, Yi ^a   Zhang, Xiong ^b   Xu, Renshi ^a  

^a NANCHANG UNIVERSITY   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Chinese Han populations; Genome wide association study; Locus; Pathway; Sporadic amyotrophic lateral sclerosis

Indexed keywords

ARACHIDONIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTROPHIN; PHOSPHATIDYLINOSITOL; T LYMPHOCYTE RECEPTOR; WNT PROTEIN;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARACHIDONIC ACID METABOLISM; ARTICLE; ATXN1 GENE; AXON GUIDANCE; C9ORF72 GENE; CHINESE HAN; CNTN4 GENE; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE; GENE LOCUS; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; ITPR2 GENE; MAJOR CLINICAL STUDY; MALE; NERVE CHARACTERISTICS AND FUNCTIONS; PATHOGENESIS; PHOSPHATIDYLINOSITOL SIGNALING SYSTEM; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SOD1 GENE; SPORADIC AMYOTROPHIC LATERAL SCLEROSIS; WNT SIGNALING PATHWAY;

CHINESE HAN POPULATIONS; GENOME-WIDE ASSOCIATION STUDY; LOCUS; PATHWAY; SPORADIC AMYOTROPHIC LATERAL SCLEROSIS;

AMYOTROPHIC LATERAL SCLEROSIS; ASIAN CONTINENTAL ANCESTRY GROUP; CHROMOSOMES, HUMAN; CONTACTINS; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MALE; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE;

EID: 85058204934     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.01.014     Document Type: Article

References (84)

1. Adeyemo A., Rotimi C. Genetic variants associated with complex human diseases show wide variation across multiple populations. Public Health Genomics 2010, 13:72-79.
2. Adibhatla R.M., Hatcher J.F. Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 2010, 12:125-169.
3. Askland K., Read C., Moore J. Pathways-based analyses of whole-genome association study data in bipolar disorder reveal genes mediating ion channel activity and synaptic neurotransmission. Hum. Genet. 2009, 125:63-79.
4. Bakir-Gungor B., Sezerman O.U. Anew methodology to associate SNPs with human diseases according to their pathway related context. PloS. One 2011, 6:e26277.
5. Baranzini S.E., Galwey N.W., Wang J., Khankhanian P., Lindberg R., Pelletier D., Wu W., Uitdehaag B.M., Kappos L., Polman C.H., Matthews P.M., Hauser S.L., Gibson R.A., Oksenberg J.R., Barnes M.R. Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum. Mol. Genet. 2009, 18:2078-2090. GeneMSA Consortium.
6. Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other. Mot. Neuron Disord 2000, 1:293-299. World Federation of Neurology Research Group on Motor Neuron Diseases.
7. Burbach B.J., Medeiros R.B., Mueller K.L., Shimizu Y. T-cell receptor signaling to integrins. Immunol. Rev. 2007, 218:65-81.
8. Cheng J., Montecalvo A., Kane L.P. Regulation of NF-κB induction by TCR/CD28. Immunol. Res. 2011, 50:113-117.
9. Chen Y., Guan Y., Liu H., Wu X., Yu L., Wang S., Zhao C., Du H., Wang X. Activation of the Wnt/β-catenin signaling pathway is associated with glial proliferation in the adult spinal cord of ALS transgenic mice. Biochem. Biophys. Res. Commun. 2012, 420:397-403.
10. Chen Y., Guan Y., Zhang Z., Liu H., Wang S., Yu L., Wu X., Wang X. Wnt signaling pathway is involved in the pathogenesis of amyotrophic lateral sclerosis in adult transgenic mice. Neurol. Res. 2012, 34:390-399.
11. Collins F.S. Reengineering translational science: the time is right. Sci. Transl. Med. 2011, 3. 90 cm17.
12. Conforti F.L., Spataro R., Sproviero W., Mazzei R., Cavalcanti F., Condino F., Simone I.L., Logroscino G., Patitucci A., Magariello A., Muglia M., Rodolico C., Valentino P., Bono F., Colletti T., Monsurrò M.R., Gambardella A., La Bella V. Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis. Neurology 2012, 79:2315-2320.
13. Contestabile A. Amyotrophic lateral sclerosis: from research to therapeutic attempts and therapeutic perspectives. Curr. Med. Chem. 2011, 18:5655-5665.
14. Corcia P., Camu W., Halimi J.M., Vourc'h P., Antar C., Vedrine S., Giraudeau B., de Toffol B., Andres C.R. SMN1 gene, but not SMN2, is a risk factor for sporadic ALS. Neurology 2006, 67:1147-1150. French ALS Study Group.
15. Couzin J., Kaiser J. Genome-wide association. Closing the net on common disease genes. Science 2007, 316:820-822.
16. Cronin S.J., Penninger J.M. From T-cell activation signals to signaling control of anti-cancer immunity. Immunol. Rev. 2007, 220:151-168.
17. Davis O.S., Plomin R., Schalkwyk L.C. The SNPMaP package for R: a framework for genome- wide association using DNA pooling on microarrays. Bioinformatics 2009, 25:281-283.
18. Debray S., Race V., Crabbé V., Herdewyn S., Matthijs G., Goris A., Dubois B., Thijs V., Robberecht W., Van Damme P. Frequency of C9orf72 repeatexpansions in amyotrophic lateral sclerosis: a Belgian cohort study. Neurobiol. Aging 2013, 34:2890.e7-2890.e12. 10.1016/j.neurobiolaging.2013.06.009.
19. de Castro F. Wiring olfaction: the cellular and molecular mechanisms that guide the development of synaptic connections from the nose to the cortex. Front. Neurosci. 2009, 3.
20. DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., Kouri N., Wojtas A., Sengdy P., Hsiung G.Y., Karydas A., Seeley W.W., Josephs K.A., Coppola G., Geschwind D.H., Wszolek Z.K., Feldman H., Knopman D.S., Petersen R.C., Miller B.L., Dickson D.W., Boylan K.B., Graff-Radford N.R., Rademakers R. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011, 72:245-256.
21. Deng M., Wei L., Zuo X., Tian Y., Xie F., Hu P., Zhu C., Yu F., Meng Y., Wang H., Zhang F., Ma H., Ye R., Cheng H., Du J., Dong W., Zhou S., Wang C., Wang Y., Wang J., Chen X., Sun Z., Zhou N., Jiang Y., Liu X., Li X., Zhang N., Liu N., Guan Y., Han Y., Han Y., Lv X., Fu Y., Yu H., Xi C., Xie D., Zhao Q., Xie P., Wang X., Zhang Z., Shen L., Cui Y., Yin X., Cheng H., Liang B., Zheng X., Lee T.M., Chen G., Zhou F., Veldink J.H., Robberecht W., Landers J.E., Andersen P.M., Al-Chalabi A., Shaw C., Liu C., Tang B., Xiao S., Robertson J., Zhang F., van den Berg L.H., Sun L., Liu J., Yang S., Ju X., Wang K., Zhang X. Genome-wide association analyses in Han Chinese identify two new susceptibility loci for amyotrophic lateral sclerosis. Nat. Genet. 2013, 45:697-700.
22. Dermitzakis E.T., Clark A.G. Genetics. Life after GWA studies. Science 2009, 326:239-240.
23. Dhandapany P.S., Sadayappan S., Xue Y., Powell G.T., Rani D.S., Nallari P., Rai T.S., Khullar M., Soares P., Bahl A., Tharkan J.M., Vaideeswar P., Rathinavel A., Narasimhan C., Ayapati D.R., Ayub Q., Mehdi S.Q., Oppenheimer S., Richards M.B., Price A.L., Patterson N., Reich D., Singh L., Tyler-Smith C., Thangaraj K. Acommon MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia. Nat. Genet. 2009, 41:187-191.
24. Edwards Y.J., Beecham G.W., Scott W.K., Khuri S., Bademci G., Tekin D., Martin E.R., Jiang Z., Mash D.C., ffrench-Mullen J., Pericak-Vance M.A., Tsinoremas N., Vance J.M. Identifying consensus disease pathways in Parkinson's disease using an integrative systems biology approach. PLoS One 2011, 6:e16917.
25. Eichler E.E., Flint J., Gibson G., Kong A., Leal S.M., Moore J.H., Nadeau J.H. Missing heritability and strategies for finding the underlying causes of complex disease. Nat. Rev. Genet. 2010, 11:446-450.
26. Elbers C.C., van Eijk K.R., Franke L., Mulder F., van der Schouw Y.T., Wijmenga C., Onland-Moret N.C. Using genome-wide pathway analysis to unravel the etiology of complex diseases. Genet. Epidemiol. 2009, 33:419-431.
27. Figueroa-Romero C., Hur J., Bender D.E., Delaney C.E., Cataldo M.D., Smith A.L., Yung R., Ruden D.M., Callaghan B.C., Feldman E.L. Identification of epigenetically altered genes in sporadic amyotrophic lateral sclerosis. PloS. One 2012, 7:e52672.
28. Gibson G. Hints of hidden heritability in GWAS. Nat. Genet. 2010, 42:558-560.
29. Giess R., Holtmann B., Braga M., Grimm T., Müller-Myhsok B., Toyka K.V., Sendtner M. Early onset of severe familial amyotrophic lateral sclerosis with a SOD-1 mutation: potential impact of CNTF as a candidate modifier gene. Am. J. Hum. Genet. 2002, 70:1277.
30. Goldstein D.B., Hirschhorn J.N. In genetic control of disease, does 'race' matter?. Nat. Genet. 2004, 36:1243-1244.
31. Gordon P.H. Amyotrophic lateral sclerosis: an update for 2013 clinical features, pathophysiology, management and therapeutic trials. Aging Dis. 2013, 4:295-310.
32. Greenway M.J., Alexander M.D., Ennis S., Traynor B.J., Corr B., Frost E., Green A., Hardiman O. Anovel candidate region for ALS on chromosome 14q11.2. Neurology 2004, 63:1936-1938.
33. Greenway M.J., Andersen P.M., Russ C., Ennis S., Cashman S., Donaghy C., Patterson V., Swingler R., Kieran D., Prehn J., Morrison K.E., Green A., Acharya K.R., Brown R.H., Hardiman O. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat. Genet. 2006, 38:411-413.
34. Grundström E., Askmark H., Lindeberg J., Nygren I., Ebendal T., Aquilonius S.M. Increased expression of glial cell line-derived neurotrophic factor mRNA in muscle biopsies from patients with amyotrophic lateral sclerosis. J.Neurol. Sci. 1999, 162:169-173.
35. Grundström E., Lindholm D., Johansson A., Blennow K., Askmark H. GDNF but not BDNF is increased in cerebrospinal fluid in amyotrophic lateral sclerosis. Neuroreport 2000, 11:1781-1783.
36. Hensley K., Mhatre M., Mou S., Pye Q.N., Stewart C., West M., Williamson K.S. On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Antioxid. Redox Signal. 2006, 8:2075-2087.
37. Holtzman D.M., Morris J.C., Goate A.M. Alzheimer's disease: the challenge of the second century. Sci. Transl. Med. 2011, 3. 77sr1.
38. Hou S.T., Jiang S.X., Smith R.A. Permissive and repulsive cues and signalling pathways of axonal outgrowth and regeneration. Int. Rev. Cell. Mol. Biol. 2008, 267:125-181.
39. Jiang Y.M., Yamamoto M., Kobayashi Y., Yoshihara T., Liang Y., Terao S., Takeuchi H., Ishigaki S., Katsuno M., Adachi H., Niwa J., Tanaka F., Doyu M., Yoshida M., Hashizume Y., Sobue G. Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann. Neurol. 2005, 57:236-251.
40. Kim E.K., Choi E.J. Pathological roles of MAPK signaling pathways in human diseases. Biochim. Biophys. Acta 2012, 1802:396-405.
41. Kraft P., Raychaudhuri S. Complex diseases, complex genes: keeping pathways on the right track. Epidemiology 2009, 20:508-511.
42. Laaksovirta H., Peuralinna T., Schymick J.C., Scholz S.W., Lai S.L., Myllykangas L., Sulkava R., Jansson L., Hernandez D.G., Gibbs J.R., Nalls M.A., Heckerman D., Tienari P.J., Traynor B.J. Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study. Lancet Neurol. 2010, 9:978-985.
43. Lambrechts D., Storkebaum E., Morimoto M., Del-Favero J., Desmet F., Marklund S.L., Wyns S., Thijs V., Andersson J., van Marion I., Al-Chalabi A., Bornes S., Musson R., Hansen V., Beckman L., Adolfsson R., Pall H.S., Prats H., Vermeire S., Rutgeerts P., Katayama S., Awata T., Leigh N., Lang-Lazdunski L., Dewerchin M., Shaw C., Moons L., Vlietinck R., Morrison K.E., Robberecht W., Van Broeckhoven C., Collen D., Andersen P.M., Carmeliet P. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet. 2003, 34:383-394.
44. Landers J.E., Melki J., Meininger V., Glass J.D., van den Berg L.H., van Es M.A., Sapp P.C., van Vught P.W., McKenna-Yasek D.M., Blauw H.M., Cho T.J., Polak M., Shi L., Wills A.M., Broom W.J., Ticozzi N., Silani V., Ozoguz A., Rodriguez-Leyva I., Veldink J.H., Ivinson A.J., Saris C.G., Hosler B.A., Barnes-Nessa A., Couture N., Wokke J.H., Kwiatkowski T.J., Ophoff R.A., Cronin S., Hardiman O., Diekstra F.P., Leigh P.N., Shaw C.E., Simpson C.L., Hansen V.K., Powell J.F., Corcia P., Salachas F., Heath S., Galan P., Georges F., Horvitz H.R., Lathrop M., Purcell S., Al-Chalabi A., Brown R.H. Reduced expression of the kinesin-associated protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A 2009, 106:9004-9009.
45. Lattante S., Conte A., Zollino M., Luigetti M., Del Grande A., Marangi G., Romano A., Marcaccio A., Meleo E., Bisogni G., Rossini P.M., Sabatelli M. Contribution of major amyotrophic lateral sclerosis genes to the etiology of sporadic disease. Neurology 2012, 79:66-72.
46. Lattante S., Rouleau G.A., Kabashi E. TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update. Hum. Mutat. 2013, 34:812-826.
47. Lesnick T.G., Papapetropoulos S., Mash D.C., Ffrench-Mullen J., Shehadeh L., de Andrade M., Henley J.R., Rocca W.A., Ahlskog J.E., Maraganore D.M. Agenomic pathway approach to a complex disease: axon guidance and Parkinson disease. PloS. Genet. 2007, 3:e98.
48. Lesnick T.G., Sorenson E.J., Ahlskog J.E., Henley J.R., Shehadeh L., Papapetropoulos S., Maraganore D.M. Beyond Parkinson disease: amyotrophic lateral sclerosis and the axon guidance pathway. PLoS One 2008, 3:e1449.
49. Lin L., Lesnick T.G., Maraganore D.M., Isacson O. Axon guidance and synaptic maintenance: preclinical markers for neurodegenerative disease and therapeutics. Trends. Neurosci. 2009, 32:142-149.
50. Liscic R.M., Breljak D. Molecular basis of amyotrophic lateral sclerosis. Prog. Neuropsycho- pharmacol. Biol. Psychiatry 2011, 35:370-372.
51. Li W., Brakefield D., Pan Y., Hunter D., Myckatyn T.M., Parsadanian A. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS. Exp. Neurol. 2007, 203:457.
52. Ludolph A.C., Brettschneider J., Weishaupt J.H. Amyotrophic lateral sclerosis. Curr. Opin. Neurol. 2012, 25:530-535.
53. Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., McCarthy M.I., Ramos E.M., Cardon L.R., Chakravarti A., Cho J.H., Guttmacher A.E., Kong A., Kruglyak L., Mardis E., Rotimi C.N., Slatkin M., Valle D., Whittemore A.S., Boehnke M., Clark A.G., Eichler E.E., Gibson G., Haines J.L., Mackay T.F., McCarroll S.A., Visscher P.M. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
54. Marsland B.J., Kopf M. T-cell fate and function: PKC-theta and beyond. Trends. Immunol. 2008, 29:179-185.
55. Masu Y., Wolf E., Holtmann B., Sendtner M., Brem G., Thoenen H. Disruption of the CNTF gene results in motor neuron degeneration. Nature 1993, 365:27-32.
56. Myles S., Davison D., Barrett J., Stoneking M., Timpson N. Worldwide population differentiation at disease-associated SNPs. BMC. Med. Genomics 2008, 1:22.
57. Pasinelli P., Brown R.H. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 2006, 7:710-723.
58. Peng G., Luo L., Siu H., Zhu Y., Hu P., Hong S., Zhao J., Zhou X., Reveille J.D., Jin L., Amos C.I., Xiong M. Gene and pathway-based second-wave analysis of genome-wide association studies. Eur. J. Hum. Genet. 2012, 18:111-117.
59. Qi Q., August A. Keeping the (kinase) party going: SLP-76 and ITK dance to the beat. Sci. STKE. 2007, 2007:pe39.
60. Rademakers R., van Blitterswijk M. Motor neuron disease in 2012: novel causal genes and disease modifiers. Nat. Rev. Neurol. 2013, 9:63-64.
61. Ravits J., Appel S., Baloh R.H., Barohn R., Brooks B.R., Elman L., Floeter M.K., Henderson C., Lomen-Hoerth C., Macklis J.D., McCluskey L., Mitsumoto H., Przedborski S., Rothstein J., Trojanowski J.Q., van den Berg L.H., Ringel S. Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis. Amyotroph. Lateral Scler. Frontotemporal. Degener. 2013, 14(Suppl 1):5-18.
62. Renton A.E., Majounie E., Waite A., Simón-Sánchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., Kalimo H., Paetau A., Abramzon Y., Remes A.M., Kaganovich A., Scholz S.W., Duckworth J., Ding J., Harmer D.W., Hernandez D.G., Johnson J.O., Mok K., Ryten M., Trabzuni D., Guerreiro R.J., Orrell R.W., Neal J., Murray A., Pearson J., Jansen I.E., Sondervan D., Seelaar H., Blake D., Young K., Halliwell N., Callister J.B., Toulson G., Richardson A., Gerhard A., Snowden J., Mann D., Neary D., Nalls M.A., Peuralinna T., Jansson L., Isoviita V.M., Kaivorinne A.L., Hölttä-Vuori M., Ikonen E., Sulkava R., Benatar M., Wuu J., Chiò A., Restagno G., Borghero G., Sabatelli M., Heckerman D., Rogaeva E., Zinman L., Rothstein J.D., Sendtner M., Drepper C., Eichler E.E., Alkan C., Abdullaev Z., Pack S.D., Dutra A., Pak E., Hardy J., Singleton A., Williams N.M., Heutink P., Pickering-Brown S., Morris H.R., Tienari P.J., Traynor B.J. Ahexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011, 72:257-268. ITALSGEN Consortium.
63. Rosenberg N.A., Huang L., Jewett E.M., Szpiech Z.A., Jankovic I., Boehnke M. Genome-wide association studies in diverse populations. Nat. Rev. Genet. 2010, 11:356-366.
64. Schadt E.E., Björkegren J.L. NEW: network-enabled wisdom in biology, medicine, and health care. Sci. Transl. Med. 2012, 4. 115rv1.
65. Schmidt E.R., Pasterkamp R.J., van den Berg L.H. Axon guidance proteins: novel therapeutic targets for ALS?. Prog. Neurobiol. 2009, 88:286-301.
66. Shriner D., Vaughan L.K., Padilla M.A., Tiwari H.K. Problems with genome-wide association studies. Science 2007, 316:1840-1842.
67. Slowik A., Tomik B., Wolkow P.P., Partyka D., Turaj W., Malecki M.T., Pera J., Dziedzic T., Szczudlik A., Figlewicz D.A. Paraoxonase gene polymorphisms and sporadic ALS. Neurology 2006, 67:766-770.
68. Steer S., Abkevich V., Gutin A., Cordell H.J., Gendall K.L., Merriman M.E., Rodger R.A., Rowley K.A., Chapman P., Gow P., Harrison A.A., Highton J., Jones P.B., O'Donnell J., Stamp L., Fitzgerald L., Iliev D., Kouzmine A., Tran T., Skolnick M.H., Timms K.M., Lanchbury J.S., Merriman T.R. Genomic DNA pooling for whole-genome association scans in complex disease: empirical demonstration of efficacy in rheumatoid arthritis. Genes. Immun. 2007, 8:57-68.
69. Stranger B.E., Stahl E.A., Raj T. Progress and promise of genome-wide association studies for human complex trait genetics. Genetics 2011, 187:367-383.
70. Sutedja N.A., Sinke R.J., Van Vught P.W., Van der Linden M.W., Wokke J.H., Van Duijn C.M., Njajou O.T., Van der Schouw Y.T., Veldink J.H., Van den Berg L.H. The association between H63D mutations in HFE and amyotrophic lateral sclerosis in a Dutch population. Arch. Neurol. 2007, 64:63-67.
71. Szelinger S., Kurdoglu A., Craig D.W. Bar-coded, multiplexed sequencing of targeted DNA regions using the Illumina genome analyzer. Methods Mol. Biol. 2011, 700:89-104.
72. Szelinger S., Pearson J.V., Craig D.W. Microarray-based genome-wide association studies using pooled DNA. Methods Mol. Biol. 2011, 700:49-60.
73. Tessier-Lavigne M., Goodman C.S. The molecular biology of axon guidance. Science 1996, 274:1123-1133.
74. Thome M. Multifunctional roles for MALT1 in T-cell activation. Nat. Rev. Immunol. 2008, 8:495-500.
75. Tiloca C., Ticozzi N., Pensato V., Corrado L., Del Bo R., Bertolin C., Fenoglio C., Gagliardi S., Calini D., Lauria G., Castellotti B., Bagarotti A., Corti S., Galimberti D., Cagnin A., Gabelli C., Ranieri M., Ceroni M., Siciliano G., Mazzini L., Cereda C., Scarpini E., Sorarù G., Comi G.P., D'Alfonso S., Gellera C., Ratti A., Landers J.E., Silani V. Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia. Neurobiol. Aging 2013, 34:1517.e9-1517.e10. SLAGEN Consortium.
76. Torkamani A., Topol E.J., Schork N.J. Pathway analysis of seven common diseases assessed by genome-wide association. Genomics 2008, 92:265-272.
77. van Es M.A., Van Vught P.W., Blauw H.M., Franke L., Saris C.G., Andersen P.M., Van Den Bosch L., de Jong S.W., van 't Slot R., Birve A., Lemmens R., de Jong V., Baas F., Schelhaas H.J., Sleegers K., Van Broeckhoven C., Wokke J.H., Wijmenga C., Robberecht W., Veldink J.H., Ophoff R.A., van den Berg L.H. ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study. Lancet Neurol. 2007, 6:869-877.
78. Veldink J.H., Kalmijn S., Van der Hout A.H., Lemmink H.H., Groeneveld G.J., Lummen C., Scheffer H., Wokke J.H., Van den Berg L.H. SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS. Neurology 2005, 65:820-825.
79. Wacholder S., Chanock S., Garcia-Closas M., El Ghormli L., Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J.Natl. Cancer Inst. 2004, 96:434-442.
80. Wang K., Li M., Bucan M. Pathway-based approaches for analysis of genomewide association studies. Am. J. Hum. Genet. 2007, 81:1278-1283.
81. Wilke R.A., Mareedu R.K., Moore J.H. The pathway less traveled: moving from candidate genes to candidate pathways in the analysis of genome-wide data from large scale pharmacogenetic association studies. Curr. Pharmacogenomics Person. Med. 2008, 6:150-159.
82. Williams S.M., Canter J.A., Crawford D.C., Moore J.H., Ritchie M.D., Haines J.L. Problems with genome-wide association studies. Science 2007, 316:1840-1842.
83. Wray N.R., Goddard M.E., Visscher P.M. Prediction of individual genetic risk to disease from genome-wide association studies. Genome Res. 2007, 17:1520-1528.
84. Yamamoto M., Mitsuma N., Inukai A., Ito Y., Li M., Mitsuma T., Sobue G. Expression of GDNF and GDNFR-alpha mRNAs in muscles of patients with motor neuron diseases. Neurochem. Res. 1999, 24:785-790.